Paul Hastings advised doValue S.p.A on the deal. doValue S.p.A (doValue), a leading European servicer of credit and real estate assets, announced the sale to Intrum, a...
doValue’s Sale of Two Non-Performing Loans Portfolios
Jaguar Global Growth Corporation I’s Business Combination with GLAAM
Paul Hastings LLP advised Jaguar Global Growth Corporation I on the deal. Jaguar Global Growth Corporation I (Nasdaq: JGGC, JGGCR, and JGGCW) announced its pending business combination...
Klaxoon’s €15 Million Series D Financing
Paul Hastings advised Eurazeo, Sofiouest and Bpifrance on the deal. Eurazeo, Sofiouest, and Bpifrance led the €15 million Series D financing of Klaxoon, a French company specialized...
Invenergy Renewables’ $1.5B Unregulated Renewables Portfolio Acquisition
Sidley Austin LLP advised Invenergy Renewables on the deal. Invenergy, the leading privately held developer, owner, and operator of sustainable energy solutions, announced IRG Acquisition Holdings...
Enbridge’s 10% Stake Acquisition in Divert Inc.
Sidley Austin LLP represented Enbridge Inc., and Latham & Watkins LLP advised Divert. Enbridge Inc. (Enbridge or the Company) (TSX: ENB) (NYSE: ENB) announced its acquisition of...
First Industrial’s $800 Million At-the-Market Offering Program
Morrison Foerster represented Wells Fargo Securities, LLC on the deal. Wells Fargo Securities, LLC acted as lead placement agent in connection with the launch of First...
Zeda’s $52 Million Series B Funding Round
O’Melveny advised Zeda, Inc. on the deal. Zeda, Inc., a global leader in advanced 3D manufacturing and nanotech solutions for the medical, space, aerospace, and defense...
Juniper Square’s Debt and Equity Financing
Goodwin Procter advised Juniper Square on the deal. Juniper Square announced a large debt and equity financing. The investment was led by Owl Rock, a division of...
TPI Composites’ $132.5 Million Convertible Notes Offering
Goodwin Procter advised TPI Composites, Inc. on the deal. Davis Polk advised the representative of the initial purchasers and the counterparties to the capped call transactions...
TCR² Therapeutics’ Agreement with Adaptimmune Therapeutics
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
Shifted Energy’s $4.3 Million Seed Funding
Goodwin advised Shifted Energy on the deal. Shifted Energy announced its $4.3 million seed funding round, which will help the company expand its energy efficiency solutions and...
Cano Health’s $150 Million Term Loan Facility
Goodwin advised Cano Health, Inc. on the deal. Cano Health, Inc. (NYSE: CANO) (the “Company”) announced its previously-announced $150 million senior secured “side-car” term loan from Diameter...